Lacosamide Injection, Solution
Product Images NDC 83854-002

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 83854-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Anthea Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Fig 1 Laco Spl)

A bar chart comparing median percentage reduction in seizure frequency from baseline between placebo and lacosamide treatments across three studies. Each study shows higher median seizure reduction with lacosamide at varying dosages compared to placebo, with statistical significance indicated. The chart includes labels for dosage and sample size.*

FDA Label Image

"image Description" (Fig 2 Laco Spl)

A cumulative distribution plot showing responder rates for Lacosamide injection at doses of 200 mg/day, 400 mg/day, and 600 mg/day compared to placebo. The y-axis represents responder rate from worsening to improvement, while the x-axis shows the percent of patients. Different line styles represent placebo and each Lacosamide dose group, with sample sizes indicated.*

FDA Label Image

"image Description" (Fig 3 Laco Spl)

A survival curve chart depicting the proportion of patients over time (days) comparing Lacosamide versus placebo. The graph shows two lines: one for placebo with a solid line and one for lacosamide with a dashed line. It includes a p-value, hazard ratio, risk reduction percentage, and confidence interval. A table at the bottom shows the number of patients at risk for both groups at various time points.*

FDA Label Image

"image Description" (Spl Carton Label Lacosamide)

Label for Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) solution for intravenous use. Manufactured by Anthea Pharma Private Limited. The label includes dosing form (injection), route (intravenous), and package size (10 single-dose 20 mL vials). The label advises dispensing the accompanying medication guide to each patient and lists inactive ingredients and storage instructions.*

FDA Label Image

"image Description" (Spl Container Label Lacosamide)

Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) intravenous solution in a 20 mL single-dose vial. Label indicates storage instructions and notes it is for intravenous use only. Manufactured by Anthea Pharma Pvt. Ltd., Hyderabad, India. Includes lot and expiration date placeholders and barcode.*

FDA Label Image

"image Description" (Structure Laco Spl)

Chemical structure of lacosamide, the active ingredient in the product LACOSAMIDE Injection, Solution. The diagram shows the molecular arrangement, including the acetyl, amino, methoxy, and benzyl functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.